|
1
|
Nichols J, Zevnik B, Anastassiadis K, Niwa
H, Klewe-Nebenius D, Chambers I, Schöler H and Smith A: Formation
of pluripotent stem cells in the mammalian embryo depends on the
POU transcription factor Oct4. Cell. 95:379–391. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Niwa H, Miyazaki J and Smith AG:
Quantitative expression of Oct-3/4 defines differentiation,
dedifferentiation or self-renewal of ES cells. Nat Genet.
24:372–376. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boyer LA, Lee TI, Cole MF, et al: Core
transcriptional regulatory circuitry in human embryonic stem cells.
Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hay DC, Sutherland L, Clark J and Burdon
T: Oct-4 knockdown induces similar patterns of endoderm and
trophoblast differentiation markers in human and mouse embryonic
stem cells. Stem Cells. 22:225–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takahashi K, Tanabe K, Ohnuki M, Narita M,
Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. Cell.
131:861–872. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park IH, Zhao R, West JA, Yabuuchi A, Huo
H, Ince TA, Lerou PH, Lensch MW and Daley GQ: Reprogramming of
human somatic cells to pluripotency with defined factors. Nature.
451:141–146. 2008. View Article : Google Scholar
|
|
7
|
Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ,
Gimotty PA, Guerra M, Guo W and Xu X: Acquired cancer stem cell
phenotypes through Oct4-mediated dedifferentiation. Oncogene.
31:4898–4911. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reers S, Pfannerstill AC, Maushagen R,
Pries R and Wollenberg B: Stem cell profiling in head and neck
cancer reveals an Oct-4 expressing subpopulation with properties of
chemoresistance. Oral Oncol. 50:155–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ,
Tsai TH, Chou SH, Chien CS, Ku HH and Lo JF: Positive correlations
of Oct-4 and Nanog in oral cancer stem-like cells and high-grade
oral squamous cell carcinoma. Clin Cancer Res. 14:4085–4095. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen YC, Hsu HS, Chen YW, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Atlasi Y, Mowla SJ, Ziaee SA and Bahrami
AR: OCT-4, an embryonic stem cell marker, is highly expressed in
bladder cancer. Int J Cancer. 120:1598–1602. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Linn DE, Yang X, Sun F, Xie Y, Chen H,
Jiang R, Chen H, Chumsri S, Burger AM and Qiu Y: A role for OCT4 in
tumor initiation of drug-resistant prostate cancer cells. Genes
Cancer. 1:908–916. 2010. View Article : Google Scholar
|
|
13
|
de Resende MF, Chinen LT, Vieira S,
Jampietro J, da Fonseca FP, Vassallo J, Campos LC, Guimarães GC,
Soares FA and Rocha RM: Prognostication of OCT4 isoform expression
in prostate cancer. Tumour Biol. 34:2665–2673. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wen K, Fu Z, Wu X, Feng J, Chen W and Qian
J: Oct-4 is required for an antiapoptotic behavior of
chemoresistant colorectal cancer cells enriched for cancer stem
cells: Effects associated with STAT3/Survivin. Cancer Lett.
333:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takeda J, Seino S and Bell GI: Human Oct3
gene family: cDNA sequences, alternative splicing, gene
organization, chromosomal location, and expression at low levels in
adult tissues. Nucleic Acids Res. 20:4613–4620. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Asadi MH, Mowla SJ, Fathi F, Aleyasin A,
Asadzadeh J and Atlasi Y: OCT4B1, a novel spliced variant of OCT4,
is highly expressed in gastric cancer and acts as an antiapoptotic
factor. Int J Cancer. 128:2645–2652. 2011. View Article : Google Scholar
|
|
17
|
Wang X, Zhao Y, Xiao Z, et al: Alternative
translation of OCT4 by an internal ribosome entry site and its
novel function in stress response. Stem Cells. 27:1265–1275. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ
and Andrews PW: OCT4 spliced variants are differentially expressed
in human pluripotent and nonpluripotent cells. Stem Cells.
26:3068–3074. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cauffman G, Liebaers I, Van Steirteghem A
and Van de Velde H: POU5F1 isoforms show different expression
patterns in human embryonic stem cells and preimplantation embryos.
Stem Cells. 24:2685–2691. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cauffman G, Van de Velde H, Liebaers I and
Van Steirteghem A: Oct-4 mRNA and protein expression during human
preimplantation development. Mol Hum Reprod. 11:173–181. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao Y, Wei J, Han J, Wang X, Su G, Zhao Y,
Chen B, Xiao Z, Cao J and Dai J: The novel function of OCT4B
isoform-265 in genotoxic stress. Stem Cells. 30:665–672. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cantz T, Key G, Bleidissel M, Gentile L,
Han DW, Brenne A and Schöler H: Absence of OCT4 expression in
somatic tumor cell lines. Stem Cells. 26:692–697. 2008. View Article : Google Scholar
|
|
23
|
Zhao S, Yuan Q, Hao H, et al: Expression
of OCT4 pseudogenes in human tumours: Lessons from glioma and
breast carcinoma. J Pathol. 223:672–682. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tay Y, Kats L, Salmena L, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karreth FA, Tay Y, Perna D, et al: In vivo
identification of tumor- suppressive PTEN ceRNAs in an oncogenic
BRAF-induced mouse model of melanoma. Cell. 147:382–395. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miranda KC, Huynh T, Tay Y, Ang YS, Tam
WL, Thomson AM, Lim B and Rigoutsos I: A pattern-based method for
the identification of microRNA binding sites and their
corresponding heteroduplexes. Cell. 126:1203–1217. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fang L, Du WW, Yang X, et al: Versican
3′-untranslated region (3′-UTR) functions as a ceRNA in inducing
the development of hepatocellular carcinoma by regulating miRNA
activity. FASEB J. 27:907–919. 2013. View Article : Google Scholar
|
|
33
|
Wang L, Guo ZY, Zhang R, et al: Pseudogene
OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4
expression by competing for miR-145 in hepatocellular carcinoma.
Carcinogenesis. 34:1773–1781. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoshino H, Enokida H, Itesako T, Kojima S,
Kinoshita T, Tatarano S, Chiyomaru T, Nakagawa M and Seki N:
Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in
renal cell carcinoma. Cancer Sci. 104:1567–1574. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Iio A, Takagi T, Miki K, Naoe T, Nakayama
A and Akao Y: DDX6 post-transcriptionally down-regulates
miR-143/145 expression through host gene NCR143/145 in cancer
cells. Biochim Biophys Acta. 1829:1102–1110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kojima S, Enokida H, Yoshino H, et al: The
tumor-suppressive microRNA-143/145 cluster inhibits cell migration
and invasion by targeting GOLM1 in prostate cancer. J Hum Genet.
59:78–87. 2014. View Article : Google Scholar
|
|
37
|
Lin F, Lin P, Zhao D, et al: Sox2 targets
cyclinE, p27 and survivin to regulate androgen-independent human
prostate cancer cell proliferation and apoptosis. Cell Prolif.
45:207–216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu N, Papagiannakopoulos T, Pan G, Thomson
JA and Kosik KS: MicroRNA-145 regulates OCT4, SOX2, and KLF4 and
represses pluripotency in human embryonic stem cells. Cell.
137:647–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cortes-Dericks L, Yazd EF, Mowla SJ,
Schmid RA and Karoubi G: Suppression of OCT4B enhances sensitivity
of lung adenocarcinoma A549 cells to cisplatin via increased
apoptosis. Anticancer Res. 33:5365–5373. 2013.PubMed/NCBI
|
|
40
|
Lin H, Sun LH, Han W, et al: Knockdown of
OCT4 suppresses the growth and invasion of pancreatic cancer cells
through inhibition of the AKT pathway. Mol Med Rep. 10:1335–1342.
2014.PubMed/NCBI
|
|
41
|
Gao Y, Wang X, Han J, Xiao Z, Chen B, Su G
and Dai J: The novel OCT4 spliced variant OCT4B1 can generate three
protein isoforms by alternative splicing into OCT4B. J Genet
Genomics. 37:461–465. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Smith JE, Alvarez-Dominguez JR, Kline N,
Huynh NJ, Geisler S, Hu W, Coller J and Baker KE: Translation of
small open reading frames within unannotated RNA transcripts in
Saccharomyces cerevisiae. Cell Rep. 7:1858–1866. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, Zhang Y, Wang Y, Zhang C, Wang Q,
Shi X, Li C, Zhang R and Li X: Functional combination strategy for
prioritization of human miRNA target. Gene. 533:132–141. 2014.
View Article : Google Scholar
|
|
44
|
Denzler R, Agarwal V, Stefano J, Bartel DP
and Stoffel M: Assessing the ceRNA hypothesis with quantitative
measurements of miRNA and target abundance. Mol Cell. 54:766–776.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ramsahoye BH, Davies CS and Mills KI: DNA
methylation: Biology and significance. Blood Rev. 10:249–261. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Leonhardt H, Rahn HP and Cardoso MC:
Functional links between nuclear structure, gene expression, DNA
replication, and methylation. Crit Rev Eukaryot Gene Expr.
9:345–351. 1999. View Article : Google Scholar
|
|
47
|
Ruvinsky A: Basics of gametic imprinting.
J Anim Sci. 77(Suppl 2): S228–S237. 1999.
|
|
48
|
Amente S, Lania L and Majello B: The
histone LSD1 demeth-ylase in stemness and cancer transcription
programs. Biochim Biophys Acta. 1829:981–986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chase A and Cross NC: Aberrations of EZH2
in cancer. Clin Cancer Res. 17:2613–2618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kellner S and Kikyo N: Transcriptional
regulation of the Oct4 gene, a master gene for pluripotency. Histol
Histopathol. 25:405–412. 2010.PubMed/NCBI
|
|
51
|
Lee YH and Wu Q: Chromatin regulation
landscape of embryonic stem cell identity. Biosci Rep. 31:77–86.
2011. View Article : Google Scholar
|
|
52
|
Das S and Levasseur D: Transcriptional
regulatory mechanisms that govern embryonic stem cell fate. Methods
Mol Biol. 1029:191–203. 2013. View Article : Google Scholar : PubMed/NCBI
|
